US 8673888
Depsipeptide for therapy of kidney cancer
granted A61KA61K38/15A61P
Quick answer
US patent 8673888 (Depsipeptide for therapy of kidney cancer) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/15, A61P, A61P35/00